Pharma Company Worried

And what worries it?

Pharmaceutical executives who recently made a major donation to an anti-marijuana legalization campaign claimed they were doing so out of concern for the safety of children — but their investor filings reveal that pot poses a direct threat to their plans to cash in on a synthetic cannabis product they have developed.

On August 31, Insys Therapeutics Inc. donated $500,000 to Arizonans for Responsible Drug Policy, becoming the single largest donor to the group leading the charge to defeat a ballot measure in Arizona to legalize marijuana.

There is more. A disclosure statement filed with the Securities and Exchange Commission:

Legalization of marijuana or non-synthetic cannabinoids in the United States could significantly limit the commercial success of any dronabinol product candidate. … If marijuana or non-synthetic cannabinoids were legalized in the United States, the market for dronabinol product sales would likely be significantly reduced and our ability to generate revenue and our business prospects would be materially adversely affected.

They have only your best interests at heart. Just ask their accountants.

And there is worse to come for them. Opioid use down in states with medical marijuana.


Posted

in

by

Tags:

Comments

2 responses to “Pharma Company Worried”

  1. […] Here is just one example from a recent post of mine. Pharmaceutical Company Supports Cannabis Prohibition To Protect Its Profits. […]

  2. […] Here is just one example from a recent post of mine. Pharma­ceu­ti­cal Company Supports Cannabis Prohi­bi­tion To Protect Its Profits. […]